technetium tc 99m pentetate has been researched along with Budd-Chiari Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ichihara, T; Kitano, T; Maeda, H; Matsumura, K; Nakatsuka, A; Takase, K; Takashiba, Y; Takeda, K; Yamakado, K | 1 |
1 other study(ies) available for technetium tc 99m pentetate and Budd-Chiari Syndrome
Article | Year |
---|---|
Binding rate constant of Tc-99m DTPA galactosyl human serum albumin measured by quantitative dynamic SPECT--clinical evaluation as a total and regional liver function test.
Topics: Adult; Aged; Budd-Chiari Syndrome; Chronic Disease; Female; Humans; Liver; Liver Diseases; Liver Function Tests; Male; Middle Aged; Radiopharmaceuticals; Reference Values; Regression Analysis; Severity of Illness Index; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Pentetate; Tomography, Emission-Computed, Single-Photon | 2001 |